• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

周期蛋白依赖性激酶 1 活性是多囊肾病囊肿生长的驱动因素。

Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease.

机构信息

Department of Internal Medicine, Yale University, New Haven, Connecticut.

Department of Pathology, Yale University, New Haven, Connecticut.

出版信息

J Am Soc Nephrol. 2021 Jan;32(1):41-51. doi: 10.1681/ASN.2020040511. Epub 2020 Oct 12.

DOI:10.1681/ASN.2020040511
PMID:33046531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7894654/
Abstract

BACKGROUND

Mutations in and , which encode the transmembrane proteins polycystin-1 and polycystin-2, respectively, cause autosomal dominant polycystic kidney disease (ADPKD). Polycystins are expressed in the primary cilium, and disrupting cilia structure significantly slows ADPKD progression following inactivation of polycystins. The cellular mechanisms of polycystin- and cilia-dependent cyst progression in ADPKD remain incompletely understood.

METHODS

Unbiased transcriptional profiling in an adult-onset mouse model before cysts formed revealed significant differentially expressed genes (DEGs) in single-knockout kidneys, which were used to identify candidate pathways dysregulated in kidneys destined to form cysts. studies validated the role of the candidate pathway in the progression of ADPKD. Wild-type and double-knockout mice that are protected from cyst growth served as controls.

RESULTS

The RNASeq data identified cell proliferation as the most dysregulated pathway, with 15 of 241 DEGs related to cell cycle functions. appeared as a central component in this analysis. expression was similarly dysregulated in models of ADPKD, and conditional inactivation of with markedly improved the cystic phenotype and kidney function compared with inactivation of alone. The / double knockout blocked cyst cell proliferation that otherwise accompanied inactivation alone.

CONCLUSIONS

Dysregulation of is an early driver of cyst cell proliferation in ADPKD due to inactivation. Selective targeting of cyst cell proliferation is an effective means of slowing ADPKD progression caused by inactivation of .

摘要

背景

分别编码跨膜蛋白多囊蛋白-1 和多囊蛋白-2 的 和 基因突变导致常染色体显性多囊肾病(ADPKD)。多囊蛋白在初级纤毛中表达,纤毛结构的破坏显著减缓了多囊蛋白失活后 ADPKD 的进展。ADPKD 中多囊蛋白和纤毛依赖性囊肿进展的细胞机制仍不完全清楚。

方法

在囊肿形成前的成年发病 小鼠模型中进行无偏转录谱分析,揭示了 单敲除肾脏中显著差异表达的基因(DEGs),这些基因被用于鉴定候选途径在注定形成囊肿的肾脏中失调。 研究验证了候选途径在 ADPKD 进展中的作用。野生型和 双敲除小鼠作为对照,它们免受囊肿生长的影响。

结果

RNASeq 数据将细胞增殖确定为最失调的途径,其中与细胞周期功能相关的 241 个 DEGs 中有 15 个。 在这项分析中表现为一个核心组成部分。 在 ADPKD 的模型中表达也同样失调,与单独失活 相比,与 条件性失活 显著改善了囊肿表型和肾功能。 / 双敲除阻止了否则伴随 单独失活的囊肿细胞增殖。

结论

由于 失活, 的失调是 ADPKD 中囊肿细胞增殖的早期驱动因素。针对囊肿细胞增殖的选择性靶向是减缓由 失活引起的 ADPKD 进展的有效方法。

相似文献

1
Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease.周期蛋白依赖性激酶 1 活性是多囊肾病囊肿生长的驱动因素。
J Am Soc Nephrol. 2021 Jan;32(1):41-51. doi: 10.1681/ASN.2020040511. Epub 2020 Oct 12.
2
Genetic reduction of cilium length by targeting intraflagellar transport 88 protein impedes kidney and liver cyst formation in mouse models of autosomal polycystic kidney disease.通过靶向鞭毛内运输88蛋白进行纤毛长度的基因降低可阻碍常染色体显性多囊肾病小鼠模型中的肾和肝囊肿形成。
Kidney Int. 2020 Nov;98(5):1225-1241. doi: 10.1016/j.kint.2020.05.049. Epub 2020 Jun 28.
3
Pkd2 Deficiency in Embryonic Aqp2 + Progenitor Cells Is Sufficient to Cause Severe Polycystic Kidney Disease.PKD2 缺失在胚胎 AQP2+祖细胞中足以导致严重的多囊肾病。
J Am Soc Nephrol. 2024 Apr 1;35(4):398-409. doi: 10.1681/ASN.0000000000000309. Epub 2024 Jan 23.
4
Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis.在一种新的常染色体显性多囊肾病(ADPKD)小鼠模型中,雷帕霉素治疗通过哺乳动物雷帕霉素靶蛋白复合物1(mTORC1)和细胞周期相关的细胞周期蛋白依赖性激酶1(CDK1)/细胞周期蛋白轴,以剂量依赖的方式改善多囊肾。
J Cell Mol Med. 2017 Aug;21(8):1619-1635. doi: 10.1111/jcmm.13091. Epub 2017 Feb 28.
5
Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model.在常染色体显性多囊肾病(ADPKD)小鼠模型中,Cux1促进细胞增殖和多囊肾病进展。
Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F1050-F1059. doi: 10.1152/ajprenal.00380.2016. Epub 2017 Jul 12.
6
Identification of pathological transcription in autosomal dominant polycystic kidney disease epithelia.常染色体显性多囊肾病上皮细胞中的病理性转录鉴定。
Sci Rep. 2021 Jul 23;11(1):15139. doi: 10.1038/s41598-021-94442-8.
7
Cell-Autonomous Hedgehog Signaling Is Not Required for Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.常染色体显性多囊肾病中,细胞自主 Hedgehog 信号传导对于囊肿形成不是必需的。
J Am Soc Nephrol. 2019 Nov;30(11):2103-2111. doi: 10.1681/ASN.2018121274. Epub 2019 Aug 26.
8
Polycystin-2-dependent transcriptome reveals early response of autosomal dominant polycystic kidney disease.多囊蛋白-2 依赖性转录组揭示常染色体显性遗传性多囊肾病的早期反应。
Physiol Genomics. 2023 Nov 1;55(11):565-577. doi: 10.1152/physiolgenomics.00040.2023. Epub 2023 Sep 18.
9
Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model.二甲双胍改善常染色体显性遗传性多囊肾病小鼠模型的相关疾病参数。
Am J Physiol Renal Physiol. 2022 Jan 1;322(1):F27-F41. doi: 10.1152/ajprenal.00298.2021. Epub 2021 Nov 22.
10
XBP1 Activation Reduces Severity of Polycystic Kidney Disease due to a Nontruncating Polycystin-1 Mutation in Mice.XBP1 激活可减轻由于非截短的多囊蛋白-1 突变导致的多囊肾病的严重程度。
J Am Soc Nephrol. 2023 Jan 1;34(1):110-121. doi: 10.1681/ASN.2021091180. Epub 2022 Oct 21.

引用本文的文献

1
Mechanistic Insights into the Pathogenesis of Polycystic Kidney Disease.多囊肾病发病机制的机制性见解
Cells. 2025 Aug 5;14(15):1203. doi: 10.3390/cells14151203.
2
ANKHD1 promotes pathogenic proliferation in Autosomal Dominant Polycystic Kidney Disease via the Cyclin D1/CDK4 pathway.ANKHD1通过细胞周期蛋白D1/细胞周期蛋白依赖性激酶4途径促进常染色体显性多囊肾病中的致病性增殖。
J Transl Med. 2025 Jun 2;23(1):612. doi: 10.1186/s12967-025-06359-9.
3
The Tumor-Associated Calcium Signal Transducer 2 (TACSTD2) oncogene is upregulated in cystic epithelial cells revealing a potential new target for polycystic kidney disease.肿瘤相关钙信号转导蛋白2(TACSTD2)癌基因在囊性上皮细胞中上调,揭示了多囊肾病的一个潜在新靶点。
PLoS Genet. 2024 Dec 12;20(12):e1011510. doi: 10.1371/journal.pgen.1011510. eCollection 2024 Dec.
4
Unravelling the Genetic Architecture of Serum Biochemical Indicators in Sheep.解析绵羊血清生化指标的遗传结构。
Genes (Basel). 2024 Jul 27;15(8):990. doi: 10.3390/genes15080990.
5
Impaired Glucose Metabolism, Primary Cilium Defects, and Kidney Cystogenesis in Glycogen Storage Disease Type Ia.糖原贮积病Ia型中的葡萄糖代谢受损、原发性纤毛缺陷与肾囊肿形成
J Am Soc Nephrol. 2024 Dec 1;35(12):1639-1654. doi: 10.1681/ASN.0000000000000452. Epub 2024 Aug 14.
6
Computational drug discovery approaches identify mebendazole as a candidate treatment for autosomal dominant polycystic kidney disease.计算药物发现方法确定甲苯咪唑为常染色体显性多囊肾病的候选治疗药物。
Front Pharmacol. 2024 May 23;15:1397864. doi: 10.3389/fphar.2024.1397864. eCollection 2024.
7
Glis2 is an early effector of polycystin signaling and a target for therapy in polycystic kidney disease.Glis2 是多囊肾病中 polycystin 信号的早期效应物,也是治疗的靶点。
Nat Commun. 2024 May 1;15(1):3698. doi: 10.1038/s41467-024-48025-6.
8
Short salsalate administration affects cell proliferation, metabolism, and inflammation in polycystic kidney disease.短期服用水杨酸盐会影响多囊肾病中的细胞增殖、代谢和炎症。
iScience. 2023 Oct 19;26(11):108278. doi: 10.1016/j.isci.2023.108278. eCollection 2023 Nov 17.
9
Polycystin-2-dependent transcriptome reveals early response of autosomal dominant polycystic kidney disease.多囊蛋白-2 依赖性转录组揭示常染色体显性遗传性多囊肾病的早期反应。
Physiol Genomics. 2023 Nov 1;55(11):565-577. doi: 10.1152/physiolgenomics.00040.2023. Epub 2023 Sep 18.
10
Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion.优先考虑多囊肾病药物靶点和从小囊性和囊性 Pkd2 模型基因表达逆转的小鼠中重新利用候选药物。
Mol Med. 2023 May 22;29(1):67. doi: 10.1186/s10020-023-00664-z.